Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …

Over the last decade, based on evidence from multiple randomized clinical trials,
transcatheter aortic valve replacement (TAVR) has become the established treatment for …

Objectives This study sought to compare outcomes in patients with bicuspid versus tricuspid
anatomy undergoing transcatheter aortic valve replacement (TAVR). Background TAVR has …

Background The postoperative outcomes of transcatheter aortic valve replacement (TAVR)
with the new generation of self-expanding valves (SEV) and balloon-expandable valves …

Objectives The aim of this study was to define predictors of prosthesis-patient mismatch
(PPM) and its impact on mortality after transcatheter aortic valve replacement (TAVR) with …

Background The SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial was
designed to compare the performance of the two most widely available commercial …

Background Treatment of aortic stenosis in patients with small annuli is challenging and can
result in prosthesis-patient mismatch (PPM). Aims We aimed to compare the forward flow …

Background Self-expanding transcatheter heart valves (THVs) are associated with better
echocardiographic hemodynamic performance than balloon-expandable THVs and are …

Background: Transcatheter aortic valve implantation (TAVI) is the preferred treatment for
symptomatic severe aortic stenosis (AS) in a majority of patients across all surgical risks …

Background Evidence of clinical impact of PPM after TAVI is conflicting and might vary
according to the type of valve implanted. Aims To assess the clinical impact of prosthesis …